This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Clinical

Suicidal thought related to pain in one in ten patients with rheumatic or musculoskeletal disease
Suicidal thought related to pain in one in ten patients with rheumatic or musculoskeletal disease
Significant gaps in essential RA care across Europe and between European countries revealed
Significant gaps in essential RA care across Europe and between European countries revealed
EULAR launches Time2Work campaign
EULAR launches Time2Work campaign
No link between cancer and TNF inhibitor use in psoriatic arthritis
No link between cancer and TNF inhibitor use in psoriatic arthritis
New biomarkers for cardiovascular risk in juvenile-onset SLE
New biomarkers for cardiovascular risk in juvenile-onset SLE
Study debunks theoretical risks of live-attenuated vaccines in paediatric rheumatic disease
Study debunks theoretical risks of live-attenuated vaccines in paediatric rheumatic disease
Scotland sees advance in treatment of kidney cancer
Scotland sees advance in treatment of kidney cancer
Phase IIIa clinical trial data presented for oral semaglutide
Phase IIIa clinical trial data presented for oral semaglutide
Protons to play a vital role in the battle against prostate cancer
Protons to play a vital role in the battle against prostate cancer
Research finds that high fibre during pregnancy reduces risk of coeliac disease in children
Research finds that high fibre during pregnancy reduces risk of coeliac disease in children
Omalizumab significantly reduced nasal polyps and congestion in chronic rhinosinusitis
Omalizumab significantly reduced nasal polyps and congestion in chronic rhinosinusitis
Long-term data from pivotal Phase III studies of ibrutinib presented at ASCO and EHA
Long-term data from pivotal Phase III studies of ibrutinib presented at ASCO and EHA


Popular articles

Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study
Ide-cel provides 51% reduction in the risk of progression or death in R/R multiple myeloma




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora